← Leaderboards
Cecilia Bergeria
Johns Hopkins University
$4,120,012
Attributed
$4,382,399
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,132,435 · 3
FDA$249,964 · 1
By mechanism
R01$3,157,348 · 1
UG3$524,774 · 1
R21$450,313 · 1
U01$249,964 · 1
Top collaborators
- Jennifer D Ellis1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Nicholas S Ialongo$26,586,427
- Meredith C McCormack$14,784,022
- Peyton A Eggleston$5,560,056
- Andrea C Gielen$24,074,508
- John D Groopman$13,586,469
Others in their field
Other Emerging Leaders on “Standardization”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$194,258,070
- Joel A Lipkin · Four Points Technology, Llc$183,862,844
- Terry Drinkwine · Carahsoft Technology Corporation$93,011,563
- Klaus Romero · Critical Path Institute$89,575,775
Research focus
StandardizationPersonsCravingTreatment OutcomeOpioidOpioid UseLabelOpioid Use DisorderPharmaceutical PreparationsReportingRelapseParticipantOutpatientsPublishingEvaluationAcuteOpioid EpidemicVisitSamplingMeasurementFda ApprovedBuspironeBuprenorphineAnxiety
Grant awards (8)
Evaluating a Mechanistically-Supported Pharmacotherapy to Treat Acute and Protracted Opioid Withdrawal$779,941
R01 · FY2025 · DA · contact PI
Validating an Opioid Craving Assessment for FDA Qualification as a Drug Development Tool$524,774
UG3 · FY2025 · DA
Evaluating a Mechanistically-Supported Pharmacotherapy to Treat Acute and Protracted Opioid Withdrawal$779,941
R01 · FY2024 · DA · contact PI
Evaluating a Mechanistically-Supported Pharmacotherapy to Treat Acute and Protracted Opioid Withdrawal$779,941
R01 · FY2023 · DA · contact PI
Developing a Clinical Outcome Assessment for Opioid Craving Using Patient Feedback (DDT-COA-000138)$249,964
U01 · FY2023 · FD · contact PI
Evaluating a Mechanistically-Supported Pharmacotherapy to Treat Acute and Protracted Opioid Withdrawal$817,525
R01 · FY2022 · DA · contact PI
Developing a Clinical Outcome Assessment for Opioid Craving$204,688
R21 · FY2022 · DA · contact PI
Developing a Clinical Outcome Assessment for Opioid Craving$245,625
R21 · FY2021 · DA · contact PI